Phase |
Liver histology |
HBV DNA |
ALT |
HBeAg |
Anti-HBe |
Duration |
Natural history |
Immune tolerance |
Minimal inflammation |
>20,000 IU/ml |
Normal |
Present |
- |
20-30 years |
Low risk of progression to advanced liver disease |
Immune clearance |
Variable inflammation +/- fibrosis |
>20,000 IU/ml (fluctuating) |
Elevated (fluctuating) |
Present |
+/- |
Can be protracted |
Associated with hepatic flares |
Immune control |
Minimal inflammation and liver damage |
<2000 IU/ml |
Normal |
Absent |
+ |
Years |
Low risk of advanced liver disease. HBsAg loss: 1% per year. 10-20% have reactivation of HBV replication after many years |
Immune escape (HBeAg negative CHB) |
Inflammation and often significant fibrosis |
2000-20,000 IU/ml |
Elevated |
Absent |
+ |
- |
Can enter this phase from immune clearance or immune control phase. High risk of progression to advanced liver disease |